nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—BCHE—diaphragm—amyotrophic lateral sclerosis	0.0482	0.252	CbGeAlD
Ephedrine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0347	0.0889	CcSEcCtD
Ephedrine—SLC18A2—Synaptic Vesicle Pathway—UNC13A—amyotrophic lateral sclerosis	0.0302	0.0721	CbGpPWpGaD
Ephedrine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0282	0.0722	CcSEcCtD
Ephedrine—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0251	0.0643	CcSEcCtD
Ephedrine—ACHE—Acetylcholine Synthesis—CHAT—amyotrophic lateral sclerosis	0.024	0.0573	CbGpPWpGaD
Ephedrine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0223	0.0572	CcSEcCtD
Ephedrine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0423	CcSEcCtD
Ephedrine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.0146	0.076	CbGeAlD
Ephedrine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0141	0.0338	CbGpPWpGaD
Ephedrine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0136	0.0349	CcSEcCtD
Ephedrine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0133	0.034	CcSEcCtD
Ephedrine—ACHE—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.013	0.0312	CbGpPWpGaD
Ephedrine—ACHE—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.0119	0.0285	CbGpPWpGaD
Ephedrine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0301	CcSEcCtD
Ephedrine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0289	CcSEcCtD
Ephedrine—ACHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.0108	0.0258	CbGpPWpGaD
Ephedrine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0264	CcSEcCtD
Ephedrine—SLC18A2—brainstem—amyotrophic lateral sclerosis	0.0102	0.0534	CbGeAlD
Ephedrine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.0101	0.0529	CbGeAlD
Ephedrine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00982	0.0252	CcSEcCtD
Ephedrine—SLC18A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.0098	0.0234	CbGpPWpGaD
Ephedrine—BCHE—Synthesis of PC—CHAT—amyotrophic lateral sclerosis	0.00962	0.023	CbGpPWpGaD
Ephedrine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00959	0.0246	CcSEcCtD
Ephedrine—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.0095	0.0227	CbGpPWpGaD
Ephedrine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00861	0.0221	CcSEcCtD
Ephedrine—SLC18A2—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.0084	0.0201	CbGpPWpGaD
Ephedrine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00824	0.0211	CcSEcCtD
Ephedrine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00815	0.0209	CcSEcCtD
Ephedrine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00807	0.0207	CcSEcCtD
Ephedrine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00786	0.0202	CcSEcCtD
Ephedrine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0198	CcSEcCtD
Ephedrine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00754	0.0193	CcSEcCtD
Ephedrine—SLC18A2—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00749	0.0179	CbGpPWpGaD
Ephedrine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00742	0.019	CcSEcCtD
Ephedrine—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.00733	0.0382	CbGeAlD
Ephedrine—ADRA1A—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.00729	0.0174	CbGpPWpGaD
Ephedrine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00725	0.0186	CcSEcCtD
Ephedrine—SLC18A2—Synaptic Vesicle Pathway—SLC1A3—amyotrophic lateral sclerosis	0.00719	0.0172	CbGpPWpGaD
Ephedrine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00715	0.0183	CcSEcCtD
Ephedrine—SLC18A2—medulla oblongata—amyotrophic lateral sclerosis	0.00714	0.0373	CbGeAlD
Ephedrine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00712	0.0183	CcSEcCtD
Ephedrine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00691	0.0177	CcSEcCtD
Ephedrine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00669	0.0171	CcSEcCtD
Ephedrine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00662	0.017	CcSEcCtD
Ephedrine—SLC6A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.00659	0.0158	CbGpPWpGaD
Ephedrine—ACHE—spinal cord—amyotrophic lateral sclerosis	0.00654	0.0341	CbGeAlD
Ephedrine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0167	CcSEcCtD
Ephedrine—ACHE—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00633	0.0152	CbGpPWpGaD
Ephedrine—SLC6A2—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.00626	0.015	CbGpPWpGaD
Ephedrine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00625	0.0326	CbGeAlD
Ephedrine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.0062	0.0159	CcSEcCtD
Ephedrine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00611	0.0157	CcSEcCtD
Ephedrine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00603	0.0155	CcSEcCtD
Ephedrine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00596	0.0153	CcSEcCtD
Ephedrine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00586	0.015	CcSEcCtD
Ephedrine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00581	0.0303	CbGeAlD
Ephedrine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0145	CcSEcCtD
Ephedrine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00542	0.0139	CcSEcCtD
Ephedrine—SLC18A2—nervous system—amyotrophic lateral sclerosis	0.00537	0.028	CbGeAlD
Ephedrine—ACHE—cerebellum—amyotrophic lateral sclerosis	0.00518	0.027	CbGeAlD
Ephedrine—SLC18A2—central nervous system—amyotrophic lateral sclerosis	0.00517	0.027	CbGeAlD
Ephedrine—BCHE—brainstem—amyotrophic lateral sclerosis	0.00517	0.027	CbGeAlD
Ephedrine—SLC18A2—cerebellum—amyotrophic lateral sclerosis	0.00505	0.0263	CbGeAlD
Ephedrine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00492	0.0126	CcSEcCtD
Ephedrine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00453	0.0116	CcSEcCtD
Ephedrine—ACHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00452	0.0108	CbGpPWpGaD
Ephedrine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00436	0.0227	CbGeAlD
Ephedrine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00436	0.0112	CcSEcCtD
Ephedrine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0111	CcSEcCtD
Ephedrine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00432	0.0111	CcSEcCtD
Ephedrine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00429	0.011	CcSEcCtD
Ephedrine—ACHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00425	0.0102	CbGpPWpGaD
Ephedrine—ACHE—brain—amyotrophic lateral sclerosis	0.00421	0.022	CbGeAlD
Ephedrine—ACHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00417	0.00999	CbGpPWpGaD
Ephedrine—SLC18A2—brain—amyotrophic lateral sclerosis	0.0041	0.0214	CbGeAlD
Ephedrine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0104	CcSEcCtD
Ephedrine—BCHE—Phospholipid metabolism—SACM1L—amyotrophic lateral sclerosis	0.00403	0.00965	CbGpPWpGaD
Ephedrine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00396	0.00947	CbGpPWpGaD
Ephedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00383	0.00917	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—FIG4—amyotrophic lateral sclerosis	0.00379	0.00907	CbGpPWpGaD
Ephedrine—BCHE—Glycerophospholipid biosynthesis—PLB1—amyotrophic lateral sclerosis	0.00372	0.00891	CbGpPWpGaD
Ephedrine—BCHE—medulla oblongata—amyotrophic lateral sclerosis	0.0036	0.0188	CbGeAlD
Ephedrine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—amyotrophic lateral sclerosis	0.00353	0.00845	CbGpPWpGaD
Ephedrine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.00327	0.0171	CbGeAlD
Ephedrine—BCHE—spinal cord—amyotrophic lateral sclerosis	0.00321	0.0168	CbGeAlD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00318	0.00761	CbGpPWpGaD
Ephedrine—ACHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00316	0.00757	CbGpPWpGaD
Ephedrine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00315	0.0165	CbGeAlD
Ephedrine—ACHE—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00312	0.00747	CbGpPWpGaD
Ephedrine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00304	0.0159	CbGeAlD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00293	0.00702	CbGpPWpGaD
Ephedrine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00293	0.0153	CbGeAlD
Ephedrine—ACHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.00291	0.00697	CbGpPWpGaD
Ephedrine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00287	0.0149	CbGeAlD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00283	0.00678	CbGpPWpGaD
Ephedrine—BCHE—Glycerophospholipid biosynthesis—CHAT—amyotrophic lateral sclerosis	0.00282	0.00675	CbGpPWpGaD
Ephedrine—BCHE—nervous system—amyotrophic lateral sclerosis	0.00271	0.0141	CbGeAlD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00264	0.00632	CbGpPWpGaD
Ephedrine—BCHE—central nervous system—amyotrophic lateral sclerosis	0.00261	0.0136	CbGeAlD
Ephedrine—BCHE—Phospholipid metabolism—PLB1—amyotrophic lateral sclerosis	0.0026	0.00622	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00259	0.0062	CbGpPWpGaD
Ephedrine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.00258	0.00617	CbGpPWpGaD
Ephedrine—BCHE—cerebellum—amyotrophic lateral sclerosis	0.00255	0.0133	CbGeAlD
Ephedrine—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00254	0.00608	CbGpPWpGaD
Ephedrine—SLC6A2—brain—amyotrophic lateral sclerosis	0.0025	0.0131	CbGeAlD
Ephedrine—SLC18A2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00244	0.00583	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00241	0.00576	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00241	0.00576	CbGpPWpGaD
Ephedrine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00233	0.0121	CbGeAlD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.0023	0.0055	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00225	0.00538	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00221	0.00528	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00217	0.00519	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00216	0.00518	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00215	0.00515	CbGpPWpGaD
Ephedrine—SLC18A2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00215	0.00514	CbGpPWpGaD
Ephedrine—BCHE—brain—amyotrophic lateral sclerosis	0.00207	0.0108	CbGeAlD
Ephedrine—ACHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.002	0.00478	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00199	0.00475	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—CHAT—amyotrophic lateral sclerosis	0.00197	0.00471	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00195	0.00467	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00195	0.00467	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00193	0.00462	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00193	0.00461	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00186	0.00445	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00185	0.00442	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00185	0.00442	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00181	0.00433	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00178	0.00426	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00176	0.00422	CbGpPWpGaD
Ephedrine—SLC18A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00174	0.00416	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGFALS—amyotrophic lateral sclerosis	0.00174	0.00416	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00172	0.00412	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00171	0.00409	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00166	0.00397	CbGpPWpGaD
Ephedrine—SLC18A2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00165	0.00394	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00164	0.00392	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00164	0.00392	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00157	0.00377	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00157	0.00374	CbGpPWpGaD
Ephedrine—ACHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00156	0.00374	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00155	0.0037	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00153	0.00366	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00153	0.00365	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00148	0.00354	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00148	0.00354	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00148	0.00354	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00148	0.00354	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00146	0.0035	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00146	0.0035	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00146	0.0035	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00146	0.00348	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00144	0.00344	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00143	0.00343	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.0014	0.00334	CbGpPWpGaD
Ephedrine—BCHE—Glycerophospholipid biosynthesis—PLA2G4A—amyotrophic lateral sclerosis	0.00139	0.00333	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00137	0.00327	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00137	0.00327	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00135	0.00324	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00135	0.00323	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00135	0.00323	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—PIGW—amyotrophic lateral sclerosis	0.00132	0.00316	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00132	0.00315	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00131	0.00314	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0013	0.00312	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0013	0.00311	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00126	0.00301	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00126	0.00301	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00122	0.00292	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00122	0.00292	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—XRN2—amyotrophic lateral sclerosis	0.00121	0.00289	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00121	0.00289	CbGpPWpGaD
Ephedrine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.00117	0.0028	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.00279	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00112	0.00268	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00112	0.00268	CbGpPWpGaD
Ephedrine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00112	0.00268	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00112	0.00268	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00112	0.00268	CbGpPWpGaD
Ephedrine—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00109	0.00261	CbGpPWpGaD
Ephedrine—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00109	0.00261	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00104	0.0025	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.001	0.00239	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000999	0.00239	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000993	0.00237	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000993	0.00237	CbGpPWpGaD
Ephedrine—BCHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.000974	0.00233	CbGpPWpGaD
Ephedrine—BCHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000973	0.00233	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000939	0.00225	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000938	0.00224	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000923	0.00221	CbGpPWpGaD
Ephedrine—SLC18A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000885	0.00212	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000881	0.00211	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000841	0.00201	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000837	0.002	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.000823	0.00197	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000786	0.00188	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000777	0.00186	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000777	0.00186	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000762	0.00182	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000762	0.00182	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000715	0.00171	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000711	0.0017	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000697	0.00167	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000693	0.00166	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00068	0.00163	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00068	0.00163	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000668	0.0016	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000668	0.0016	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000661	0.00158	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000648	0.00155	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000634	0.00152	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000622	0.00149	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000609	0.00146	CbGpPWpGaD
Ephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000595	0.00142	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000591	0.00141	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000589	0.00141	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000578	0.00138	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000572	0.00137	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000551	0.00132	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000544	0.0013	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000492	0.00118	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000488	0.00117	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000474	0.00113	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00044	0.00105	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000435	0.00104	CbGpPWpGaD
Ephedrine—ADRA1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000432	0.00103	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000418	0.000999	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00041	0.00098	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000404	0.000967	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000385	0.000922	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000373	0.000893	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000373	0.000891	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000367	0.000878	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000351	0.00084	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000344	0.000822	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000339	0.000811	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000334	0.0008	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000317	0.000757	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000313	0.000749	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000312	0.000747	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000304	0.000726	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000289	0.000691	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000286	0.000684	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000282	0.000675	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000282	0.000675	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000269	0.000643	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000258	0.000618	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000258	0.000616	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000255	0.00061	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000247	0.000591	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000237	0.000566	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000222	0.000532	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000219	0.000524	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000217	0.000519	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000211	0.000504	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000206	0.000493	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000204	0.000489	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000198	0.000473	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000184	0.00044	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000181	0.000434	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000181	0.000434	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000179	0.000429	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000177	0.000422	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000176	0.000422	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00017	0.000407	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.00016	0.000383	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000156	0.000374	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000152	0.000363	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00015	0.000359	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000149	0.000356	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000146	0.000349	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00014	0.000334	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000139	0.000334	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000133	0.000318	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000132	0.000317	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000129	0.000308	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000123	0.000295	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000116	0.000276	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000115	0.000274	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000114	0.000272	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00011	0.000263	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000107	0.000256	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	9.46e-05	0.000226	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.42e-05	0.000225	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.86e-05	0.000212	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.81e-05	0.000211	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.81e-05	0.000211	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.86e-05	0.000188	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.83e-05	0.000187	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.29e-05	0.000174	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	7.28e-05	0.000174	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.02e-05	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.6e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.3e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.75e-05	0.000114	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.63e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.38e-05	0.000105	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.93e-05	9.41e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.59e-05	8.59e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.97e-05	7.11e-05	CbGpPWpGaD
